LEWIS: The need for a cure incentive

Guest Column

LEWIS: Listening generously

Guest Column

LEWIS: Saving basic science

Guest Column

Yale professors shape New Haven biotech culture

Sci-Tech

Obama announces cancer “moonshot”

Sci-Tech

Pharmaceutical incentives cost lives, Yale professor says

A Yale paper published online on Feb. 11 in the Journal of Global Health argues that implementation of a new agency to fund pharmaceutical companies could have decreased the severity of the recent Ebola outbreak.

Sci-Tech

Study uncovers science behind “the munchies”

A study led by Yale researchers has uncovered a novel contribution of a subset of neurons in driving marijuana induced feeding, otherwise known as “the munchies.”

Sci-Tech

A promising personalized medicine initiative, but little funding

The National Institutes of Health is slated to receive $215 million with the hope of individualizing medical treatments by using patients’ genetic information.

Sci-Tech

Risks can outweigh benefits in treatment of older diabetes patients

A study from a team of researchers at Yale and the University of California at San Francisco suggests that doctors across the nation are over-treating older diabetes patients to tightly control blood sugar, and that the risks of doing so — low blood sugar episodes resulting from too much insulin — outweigh the benefits.

Sci-Tech

Contrary to popular perception, not a mellow high

It may be viewed as a mellow drug, but a new study from the Yale School of Medicine calls that widely accepted perception about pot into question.

Sci-Tech

Yo-Yo Ma performs benefit concert

Last night, internationally acclaimed cellist Yo-Yo Ma shared the stage with Yale faculty and students for his first performance at the University since 1987.

Culture

Immunotherapy shows promise in cancer treatment

A team of researchers, led by scientists at Yale and the biotech company Genentech, have completed a phase I clinical trial for a new cancer immunotherapy and developed biomarkers to predict its efficacy in patients. The trial’s results look promising for the potential to use personalized medicine and immunotherapies to treat cancer.

Sci-Tech